Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?-Reference-Cited by-同舟云学术

Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?

Published:2014-01-15 Issue:1 Volume:9 Page:e85198
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Bergen Cornelis A. M.,Verdegaal Elisabeth M. E.,Honders M. Wilhelmina,Hoogstraten Conny,Steijn-van Tol A. Q. M. Jeanne,de Quartel Linda,de Jong Joan,Meyering Maaike,Falkenburg J. H. Frederik,Griffioen Marieke,Osanto Susanne

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. The current status of hematopoietic cell transplantation;FR Appelbaum;Annu Rev Med,2003

2. Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses;X Feng;Trends Immunol,2008

3. Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab;PA von dem Borne;Haematologica,2006

4. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation;R Childs;N Engl J Med,2000

5. Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after;SS Tykodi;Expert Opin Biol Ther,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool;Proceedings of the National Academy of Sciences;2022-07-08

2. The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction;Frontiers in Immunology;2020-06-24

3. Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma;Oncology Letters;2018-03-30

4. Current Immunotherapies for Renal Cell Carcinoma;Current Molecular Pharmacology;2016-09-05

5. Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets;Frontiers in Immunology;2016-03-15